No matter the task, we're tracking every last dollar from start to finish. Up next: treating scalp psoriasis. Psoriasis is a common skin disease that affects about two percent of the population in the ...
The trial also met key secondary endpoints, including a greater percentage of patients achieving a 90% improvement in Psoriasis Scalp Severity Index (PSSI) response and a change from baseline in ...